CD19 Tyrosine-mediated Signal Transduction in vivo
CD19 酪氨酸介导的体内信号转导
基本信息
- 批准号:7647892
- 负责人:
- 金额:$ 36.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-01-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAdoptive TransferAffinityAntibody FormationAntigen-Antibody ComplexAntigensAutoantibodiesAutoimmune DiseasesAutoimmunityB-Cell ActivationB-LymphocytesBloodBlood CirculationCD19 geneCD19 tyrosineCell Surface ReceptorsCellsDataDefectDendritic CellsDendritic cell activationFailureFollicular Dendritic CellsGenerationsGoalsHomingHost DefenseHourHumanImmunityImmunizationImmunoglobulin MImmunologic MemoryInfectionIntegral Membrane ProteinKidney DiseasesLeadLinkLupusMature B-LymphocyteMediatingMemory B-LymphocyteModelingMusPathway interactionsPhysiologicalPhysiologyProcessProductionProteinsPublishingRecoveryRecruitment ActivityRegulationReportingRoleSLEB1 geneSclerodermaSequence AnalysisSignal TransductionSiteSpleenStructure of germinal center of lymph nodeTestingTransgenesVaccinationVaccinesVasculitisbasecell motilityin vivomacrophagepathogenpublic health relevancereconstitutionresearch studyresponsetooltrafficking
项目摘要
DESCRIPTION (provided by applicant): B lymphocytes are required for host defense against infectious pathogens but abnormal activation of B cells can lead to autoimmunity. Thus, B cells are important in a wide range of physiologic and pathophysiologic processes. Mature B cells in the spleen enter into one of two compartments, the marginal zone or the follicular. Marginal zone B cells are responsible for rapid responses to pathogens that have reached the circulation. Follicular B cells are recruited into germinal centers, where affinity maturation and the generation of memory B cells lead to heightened responses upon subsequent encounters with a pathogen, which is crucial to immunization by vaccines. Mice lacking CD19, a B cell surface receptor, fail to form marginal zone B cells or germinal centers and have a propensity to produce autoantibodies. Our new data demonstrate that lack of marginal zone B cells results in defects in other components of the marginal zone, including marginal zone macrophages and dendritic cells. However, the macrophages and dendritic cells reappear following reconstitution of the marginal zone B cells by adoptive transfer of wild type B cells. Aim 1 will dissect the mechanisms by which CD19 on B cells regulates the differentiation of MZ B cells, and thereby other constituents of the marginal zone. Additional new preliminary data suggest that that failure to form germinal centers is associated with a failure of activation of Follicular Dendritic Cells (FDC) in CD19-/- mice. Adoptive transfer of wild type B cells also reconstitutes the ability to activate FDC in CD19-/- recipient mice, which recover the ability to form germinal centers. In Aim 2, we will test three hypotheses as to how CD19- dependent mechanisms regulate FDC: through activation of follicular B cells, through effects on the marginal zone that control delivery of antigen to FDC, and through formation of immune complexes. In Aim 3, we will determine how CD19 regulates autoimmunity by experiments to test the role of CD19 in central selection, selection in the periphery, and in a model of autoimmunity. These aims are proposed not just to understand the function of CD19, but to use CD19 to probe basic mechanisms that are fundamental to immunization and protection from pathogens, without autoimmunity. Public Health Relevance: The marginal zone of the spleen is required for survival of infections that have reached the blood while germinal centers are of fundamental importance in vaccination and immunological memory. Despite their crucial roles in protection from infections, the marginal zone and the germinal center responses are poorly understood. This project will use CD19, a protein expressed on B lymphocytes that is required for both types of response, as a tool to investigate the functions of B cells in the marginal zone and in germinal centers in vivo.
描述(由申请方提供):宿主防御感染性病原体需要B淋巴细胞,但B细胞的异常激活可导致自身免疫。因此,B细胞在广泛的生理和病理生理过程中是重要的。脾脏中成熟的B细胞进入两个区室之一,边缘区或滤泡。边缘带B细胞负责对已经到达循环的病原体的快速反应。滤泡B细胞被募集到生发中心,在那里亲和力成熟和记忆B细胞的产生导致在随后遇到病原体时的增强的应答,这对疫苗的免疫至关重要。缺乏CD 19(一种B细胞表面受体)的小鼠不能形成边缘区B细胞或生发中心,并有产生自身抗体的倾向。我们的新数据表明,边缘区B细胞的缺乏导致边缘区其他成分的缺陷,包括边缘区巨噬细胞和树突状细胞。然而,巨噬细胞和树突状细胞在通过野生型B细胞的过继转移重建边缘区B细胞后重新出现。目的1将剖析B细胞上的CD 19调节MZ B细胞分化的机制,从而调节边缘区的其他成分。其他新的初步数据表明,未能形成生发中心与CD 19-/-小鼠中滤泡树突状细胞(FDC)活化失败有关。野生型B细胞的连续转移也重建了激活CD 19-/-受体小鼠中FDC的能力,其恢复了形成生发中心的能力。在目标2中,我们将检验关于CD 19依赖性机制如何调节FDC的三个假设:通过激活滤泡B细胞,通过对控制抗原向FDC递送的边缘区的影响,以及通过形成免疫复合物。在目标3中,我们将通过实验来确定CD 19如何调节自身免疫,以测试CD 19在中心选择、外周选择和自身免疫模型中的作用。提出这些目标不仅是为了了解CD 19的功能,而且是为了利用CD 19探索免疫和保护免受病原体侵害的基本机制,而不是自身免疫。公共卫生相关性:脾脏的边缘区是到达血液的感染存活所必需的,而生发中心在疫苗接种和免疫记忆中具有根本的重要性。尽管它们在保护免受感染方面起着至关重要的作用,但边缘区和生殖中心的反应却知之甚少。本项目将使用CD 19(一种在B淋巴细胞上表达的蛋白质,这两种类型的反应都需要这种蛋白质)作为研究体内边缘区和生殖中心B细胞功能的工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LOUIS B JUSTEMENT其他文献
LOUIS B JUSTEMENT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LOUIS B JUSTEMENT', 18)}}的其他基金
Identification and Analysis of the Physiological Ligand for TLT2
TLT2生理配体的鉴定与分析
- 批准号:
8568235 - 财政年份:2013
- 资助金额:
$ 36.25万 - 项目类别:
CD19 Tyrosine-mediated Signal Transduction in vivo
CD19 酪氨酸介导的体内信号转导
- 批准号:
8081969 - 财政年份:2010
- 资助金额:
$ 36.25万 - 项目类别:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
HSH2 对 B 淋巴细胞存活和分化的调节
- 批准号:
7612425 - 财政年份:2008
- 资助金额:
$ 36.25万 - 项目类别:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
HSH2 对 B 淋巴细胞存活和分化的调节
- 批准号:
7191849 - 财政年份:2007
- 资助金额:
$ 36.25万 - 项目类别:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
HSH2 对 B 淋巴细胞存活和分化的调节
- 批准号:
7367189 - 财政年份:2007
- 资助金额:
$ 36.25万 - 项目类别:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
HSH2 对 B 淋巴细胞存活和分化的调节
- 批准号:
8030421 - 财政年份:2007
- 资助金额:
$ 36.25万 - 项目类别:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
HSH2 对 B 淋巴细胞存活和分化的调节
- 批准号:
7586201 - 财政年份:2007
- 资助金额:
$ 36.25万 - 项目类别:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
HSH2 对 B 淋巴细胞存活和分化的调节
- 批准号:
7775050 - 财政年份:2007
- 资助金额:
$ 36.25万 - 项目类别:
CD19 Tyrosine-mediated Signal Transduction in vivo
CD19 酪氨酸介导的体内信号转导
- 批准号:
7533208 - 财政年份:1998
- 资助金额:
$ 36.25万 - 项目类别:
CD19 Tyrosine-mediated Signal Transduction in vivo
CD19 酪氨酸介导的体内信号转导
- 批准号:
8289609 - 财政年份:1998
- 资助金额:
$ 36.25万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 36.25万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 36.25万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 36.25万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 36.25万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 36.25万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 36.25万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 36.25万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 36.25万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 36.25万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 36.25万 - 项目类别:














{{item.name}}会员




